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Tolerance to self-antigens is a key feature of the 
immune system. Systemic autoimmune diseases, 
such as systemic lupus erythematosus (SLE), re-
sult from dysregulation of B and T cell activa-
tion and altered function of macrophages and 
DCs (Shlomchik, 2009), leading to pathogenic 
autoantibodies, which are IgG isotype switched, 
high  affinity  to  self-antigens,  and  somatically 
hypermutated.  (Rothfield  and  Stollar,  1967; 
Diamond and Scharff, 1984). Although B cells 
are the proximal cells in the phenotypic manifes-
tations of SLE, interactions with other immune 
cell types are dynamically involved (MacLennan, 
1994; Shlomchik et al., 2001; Craft, 2011).
Recently,  a  polymorphism  of  Blimp-1  has 
been identified as a risk factor in SLE by genome-
wide association studies, suggesting a critical func-
tion of Blimp-1 in SLE (Gateva et al., 2009; Han 
et al., 2009). Blimp-1 negatively regulates expres-
sion of IFN- in both humans and mice (Keller 
and Maniatis, 1991; Turner et al., 1994). In B cells, 
Blimp-1 is a key regulator of plasma cell develop-
ment  (Shapiro-Shelef  et  al.,  2003).  In T  cells, 
Blimp-1 regulates the differentiation of TH1 and 
the function of regulatory T cells (Martins et al., 
2006). Blimp-1 was suggested to be a survival fac-
tor in monocytes (Chang et al., 2000); however, a 
more recent study using a Tie2–CRE system has 
suggested that Blimp-1 may regulate the differen-
tiation and activation of DCs (Chan et al., 2009). 
In that study, IL-6 and MCP-1 were shown to 
be direct targets of Blimp-1 and the deletion 
of Blimp-1 resulted in increased expression 
of proinflammatory cytokines. The physiological 
importance of Blimp-1 specifically in DCs, how-
ever, could not be addressed in this mouse model 
in which Blimp-1 was deleted in all hemato-
poietic cell lineages.
DCs are important in lupus pathogenesis, al-
though a primary defect in DC function has not 
been reported. Because DCs were discovered by 
Steinman and Cohn (1973), they have been rec-
ognized as the key immune-regulating cells. DCs 
can mediate both immune tolerance and immune 
activation (Cools et al., 2007). DCs can acquire 
tolerogenic  phenotype  after  phagocytosis  of 
apoptotic cells (Qiu et al., 2009). They can also 
generate regulatory T (Treg) cells or cause immune 
suppression by secretion of cytokines (Yamazaki 
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Blimp-1 has been identified as a key regulator of plasma cell differentiation in B cells and 
effector/memory function in T cells. We demonstrate that Blimp-1 in dendritic cells (DCs) 
is required to maintain immune tolerance in female but not male mice. Female mice lacking 
Blimp-1 expression in DCs (DCBlimp-1ko) or haploid for Blimp-1 expression exhibit normal 
DC development but an altered DC function and develop lupus-like autoantibodies. Al-
though DCs have been implicated in the pathogenesis of lupus, a defect in DC function has 
not previously been shown to initiate the disease process. Blimp-1ko DCs display increased 
production of IL-6 and preferentially induce differentiation of follicular T helper cells  
(TFH cells) in vitro. In vivo, the expansion of TFH cells is associated with an enhanced germinal 
center (GC) response and the development of autoreactivity. These studies demonstrate a 
critical role for Blimp-1 in the tolerogenic function of DCs and show that a diminished 
expression of Blimp-1 in DCs can result in aberrant activation of the adaptive immune 
system with the development of a lupus-like serology in a gender-specific manner. This 
study is of particular interest because a polymorphism of Blimp-1 associates with SLE.
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mice produced increased IL-6 and preferentially induced dif-
ferentiation of TFH cells. All aspects of the phenotype were 
abolished in DCBlimp-1ko mice haploid for IL-6. Together, 
these observations suggest that a defect restricted to DCs can 
alter T cell differentiation resulting in the production of high 
titers of lupus-like autoantibodies in a gender-specific fashion.
RESULTS AND DISCUSSION
Gender-dependent development of autoantibodies  
in DCBlimp-1ko mice
Blimp-1 expression was measured by Western blotting (Fig. 1 A).   
CD11chi DCs were purified from spleens of age-matched 
DCBlimp-1ko  (Blimp-1flox/flox;  CD11c-CRE+)  and  control 
et al., 2008). Although differentiation of DCs into immunogenic 
or tolerogenic DCs has not been fully characterized, it is gener-
ally accepted that DC maturation status rather than DC lineage 
alone determines the functionality of DCs (Cools et al., 2007).
In this study, DCBlimp-1ko mice were generated by mating 
Blimp-1flox mice to CD11c-CRE+ mice to identify the in vivo 
consequences of Blimp-1 deficiency to DC function. Female, 
but not male, DCBlimp-1ko mice developed autoantibodies 
with extensive mutations, suggesting their maturation in a ger-
minal center (GC) response. Consistent with this observation, 
female mice display increased GC formation in the basal state 
and  after  immunization,  accompanied  by  an  increased  fre-
quency of TFH cells. Finally, DCs from female DCBlimp-1ko 
Figure 1.  Deletion of Blimp-1 in DCs and phenotype of DCBlimp-1ko mice. (A) Expression of Blimp-1 in DCs and plasma cells by Western blotting. Cell 
lysates from 5 × 105 BM-DCs, splenic DCs, and plasma cells of control mice were loaded (top). DCs from spleens of control and DCBlimp-1ko mice were used. The 
level of Blimp-1 was compared in splenic DCs from control (CRE) and Blimp-1ko (CRE+) female and male mice. Representative data from three independent ex-
periments are shown. (B) Anti-dsDNA IgG in serum of control and DCBlimp-1ko mice by ELISA. Mean ± SD of three independent experiments is shown. n = 8. The 
bottom shows representative pictures of ANA. (C) Isotype-specific anti-dsDNA ELISA. Mean ± SD of three independent experiments is shown. n = 7. (D) 24-h urine 
samples were collected from 8–10-mo-old control and DCBlimp-1ko mice and protein was measured. IgG deposition and histology of kidneys from 8-mo-old con-
trol and DCBlimp-1ko mice. Pictures are representative of each strain. Bars: (IgG) 20 µm; (histology) 40 µm. Horizontal bars indicate mean. (E) Anti-dsDNA and anti-
ENA5 IgG in serum from 6–8-mo-old control and DCBlimp-1ko female and male mice by ELISA. Mean ± SD of three independent experiments is shown. n > 10.JEM Vol. 208, No. 11  2195
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and, most surprisingly, downstream effects of Blimp-1 defi-
ciency are gender specific.
Increased expression of IL-6 in Blimp-1ko DCs
To understand the alterations in Blimp-1ko DCs responsible 
for the generation of autoantibodies, we analyzed the charac-
teristics of the DCs. Because the expression of IL-6 is regu-
lated by Blimp-1 (Chan et al., 2009) and enhanced expression 
of IL-6 is associated with SLE, and possibly related to DC ac-
tivation (Colonna et al., 2006; Jeon et al., 2010), we exam-
ined IL-6 production. We observed an increased production 
of IL-6 by splenic Blimp-1ko DCs compared with control DCs 
(Fig. 2 A) and by BM-DCs after LPS stimulation (Fig. 2 B). 
In male mice, however, there was no significant difference in 
the level of IL-6 produced by either splenic DCs or BM-DCs 
from control or DCBlimp-1ko mice (Fig. 2, A and B). In fact, 
production of IL-6 was higher in female than in male con-
trol DCs, implicating a sex difference in cytokine produc-
tion even in wild type DCs. This observation is consistent 
with data in patients showing an association of an estrogen- 
sensitive polymorphism of the IL-6 promoter with suscepti-
bility to type I diabetes in women (Kristiansen et al., 2003). 
The level of expression of several genes also increased in 
Blimp-1ko DCs as measured by quantitative (q) PCR (Table S2). 
Bcl-6, a molecule negatively regulated by Blimp-1, was up-
regulated in Blimp-1ko DCs. Expression of XBP, which has 
been demonstrated to be a survival factor for DCs (Iwakoshi 
et al., 2007), was equivalent in control and Blimp-1ko DCs, 
supporting our observation that activation not development 
is affected by Blimp-1 deficiency.
IL-6 overexpression was of particular interest because IL-6 
has been shown to affect several B cell functions, including 
GC formation and antibody secretion by plasma cells (Kopf   
et al., 1998; Cassese et al., 2003), and to participate in the 
differentiation of TF H cells (Nurieva et al., 2009). To test the 
importance  of  increased  IL-6  in  autoantibody  production   
in  DCBlimp-1ko  mice,  we  generated  DCBlimp-1ko  mice 
(either Blimp-1+/+; CD11c-CRE+ or Blimp-1flox/flox; CD11c-
CRE)  mice.  Splenic  DC  expression  of  Blimp-1  in   
DCBlimp-1ko mice was barely detectable compared with 
control DCs in both female and male. DCs from Blimp-1flox/+; 
CRE+ mice displayed an intermediate level of expression. 
Deletion of Blimp-1 is DC specific because the Blimp-1 level 
was unaffected in B cells, NK cells, macrophages, and -CD3/
CD28–activated T cells (Fig. S1 A).
Consistent with a previous study (Chan et al., 2009), de-
velopment of DCs was normal in both conventional DCs 
(cDCs;  CD11chiSiglec-H)  and  plasmacytoid  DCs  (pDCs; 
CD11cloSiglec-H+)  in  the  spleen  or  in  BM-derived  DCs 
(BM-DCs; Fig. S1 B). However, female DCBlimp-1ko mice 
developed autoantibodies as early as 4–5 mo of age. Sera from 
age-matched female DCBlimp-1ko mice and control mice 
were assayed for anti-nuclear antibody (ANA), anti-double-
stranded (ds) DNA, and anti-ENA5 by ELISA. All the ANA-
positive immunoglobulin was IgG; IgM ANA was negligible 
(Fig. 1 B and not depicted). Moreover, sera from DCBlimp-1ko 
mice displayed IgG reactivity to both dsDNA and ENA5 
(Fig. 1 E). Mice haploid for Blimp-1 also displayed IgG   
reactivity to dsDNA antibodies. An isotype-specific ELISA 
demonstrated that IgG2b is the major isotype of anti-dsDNA 
antibodies (Fig. 1 C). Proteinuria was developed, and kidney 
deposition of IgG and mesangial cell proliferation and inflam-
matory infiltrates were observed in 10-mo-old DCBlimp-1ko 
mice (Fig. 1 D). In contrast to the results from female mice, 
serum from male DCBlimp-1ko mice displayed no anti- 
dsDNA or ENA5 reactivity (Fig. 1 E). Similarly, total serum 
immunoglobulin levels and number of splenocytes are signifi-
cantly increased in female but not in male DCBlimp-1ko mice 
(Fig. S2 A and Table S1). The gender disparity in DCBlimp-1ko 
mice is interesting because most lupus mouse models dem-
onstrate  a  lupus-like  phenotype  in  both  genders.  Overall, 
these data suggest that expression of Blimp-1 in DCs plays a 
critical role in tolerance against self-reactivity. Moreover, hap-
losufficient expression is not sufficient for immune tolerance, 
Figure 2.  Increased expression of IL-6  
in Blimp-1ko DCs from female mice and 
IL-6–dependent autoantibody generation. 
Splenic DCs (A) and BM-DCs (B) were pre-
pared as described in Materials and methods 
and cultured with or without LPS stimulation. 
IL-6 in the supernatant was measured by 
ELISA. Mean ± SD of three independent ex-
periments is shown. n = 6. (C) IL-6 secretion 
by purified splenic DCs of control, DCBlimp-1ko, 
and IL-6+/ DCBlimp-1ko. Mean ± SD of three 
independent experiments is shown. n = 5.  
(D) Serum from 4-mo-old mice was obtained, 
and the level of dsDNA and ENA5 IgG was 
measured as described in Materials and meth-
ods. Each dot represents an individual mouse 
and horizontal bars indicate mean.2196 Tolerogenic function of Blimp-1 in dendritic cells | Kim et al.
Flow cytometry and immunohistochemistry (IHC) dem-
onstrated an enhanced GC response in young mice (8–12 wk 
old); many more spontaneous GC B cells, as well as GCs in 
spleens, were present in DCBlimp-1ko mice (Fig. 3 B). In con-
trast to the response in IL-6+/ DCBlimp-1ko mice, there   
was an enhanced immune response in DCBlimp-1ko mice   
after NP-CGG immunization with an increased high-affinity 
anti-NP IgG response (Fig. S3 B). There was an increased 
number of GC B cells (Fig. S3 C) and an increased number of 
total GCs (Fig. S3 D) as well as antigen-specific GCs (7/12 + 
GCs in DCBlimp-1ko mice and 1/3 + GCs in control mice).
Blimp-1ko DCs induce expansion of TFH cells in vivo and in vitro
TFH  cells  in  GCs  provide  direct  help  to  antigen-specific   
B cells (Garside et al., 1998). The importance of tight regula-
tion of expression of the costimulatory molecule inducible 
co-stimulator (ICOS) on CD4+ TFH cells has been demon-
strated  in  studies  of  lupus-prone  sanroque  mice  (Vinuesa   
et al., 2005); moreover, ICOS blockade inhibits lupus in 
NZB/W F1 mice (Hu et al., 2009).
To address whether there were more activated CD4+ T cells 
in DCBlimp-1ko mice, we measured ICOS expression on T cells. 
There was increased expression of ICOS in CD4+ T cells from 
DCBlimp-1ko mice compared with control mice (Fig. S4 A). In 
addition, the percentage and the number of TFH cells were also 
increased in DCBlimp-1ko mice (Fig. 4 A and Fig. S4 B).
Several studies have suggested that specific subsets of DCs 
preferentially induce different helper T cells (Maldonado-López 
haploid for IL-6 (IL-6+/ DCBlimp-1ko). DCs from IL-6+/ 
DCBlimp-1ko mice express the same level of IL-6 as DCs 
from control mice after LPS stimulation (Fig. 2 C). Immuni-
zation of control and IL-6+/ DCBlimp-1ko mice with NP-
CGG  showed  that  IL-6+/  DCBlimp-1ko  mice  mount  an 
antibody response that is indistinguishable from that of control 
mice (Fig. S3 A), demonstrating that B cells from IL-6+/ 
DCBlimp-1ko mice are not defective in antibody production 
or affinity maturation. Although IL-6+/ DCBlimp-1ko mice 
had a normal antibody response to immunization, they did 
not develop autoantibodies (Fig. 2 D). These data suggest that 
the increased expression of IL-6 by DCs contributes to the 
generation of autoantibodies in female DCBlimp-1ko mice.
Enhanced GC formation in DCBlimp-1ko mice
Because we observed only IgG, and not IgM, autoantibodies, 
we asked whether the autoantibodies were derived from GC-
experienced B cells. We generated hybridomas of splenocytes 
from 4-mo-old DCBlimp-1ko mice. There were 27 ANA-
positive clones from 304 IgG-secreting clones (10%). From 
the 27 clones, 13 and 16 clones were successfully sequenced for 
heavy and light chain, respectively. Sequence analysis revealed 
a high incidence of mutation in most clones (Fig. 3 A). Inter-
estingly, 3 out of 13 clones contained an arginine residue ac-
quired by point mutation in the complementary determining 
region 3 in the heavy chain, which is often seen in high-affinity 
anti-DNA antibodies. These data suggest that autoantibodies 
are produced by GC-matured plasma cells.
Figure 3.  Characterization of ANA IgG and GC response. (A) Sequence analysis of ANA IgG from hybridomas. Hybridomas were generated by spleno-
cytes of 4-mo-old DCBlimp-1ko mice. Total heavy and light chain of ANA-positive IgG was amplified and sequenced. Mutations were determined by 
comparison with the mouse genomic sequence database. Numbers in each pie graph represent the number of clones categorized by the number of muta-
tion (n = 4). (B) Spontaneous GC formation in the spleen of 6–10-wk-old DCBlimp-1ko mice. GC (PNA+ B220+, asterisks) was analyzed by IHC. Pictures are 
representative images (bars, 100 µm). On the right, GL-7+B220+ GC B cells were quantified by flow cytometry as depicted in representative pictures. Each 
dot represents an individual mouse and horizontal bars indicate means of three independent experiments.JEM Vol. 208, No. 11  2197
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The importance of IL-6 was further demonstrated in vitro as 
–IL-6 neutralizing antibody inhibited the differentiation of 
T cells co-cultured with control DCs and Blimp-1ko DCs into 
TFH (Fig. S5). These observations suggest that the increased 
generation of TFH cells results from increased IL-6 production 
by DCs in DCBlimp-1ko mice. Interestingly, there was no 
significant increase in TH17 cells, another subset for which IL-6 
is critical (unpublished data), suggesting that additional re-
quirements for the generation of TH17 must exist and are not 
provided by Blimp-1ko DCs.
IL-6–dependent generation of GC B cells and TFH cells
Because increased TFH cells and GC response are important 
mechanisms for autoantibody production in DCBlimp-1ko mice 
and the phenotype was impaired in IL-6+/ DCBlimp-1ko mice, 
we  compared  GC  and  TFH  cells  in  IL-6+/  DCBlimp-1ko  
mice. IL-6+/ DCBlimp-1flox/+ mice showed a reduced num-
ber of TFH cells as well as a reduced number of GC cells in 
the spleen (Fig. 5). These data suggest that the in-
creased expression of IL-6 in Blimp-1ko DCs is a 
et al., 1999). We reasoned that the increased number of TFH 
was dependent on DC function in DCBlimp-1ko mice; there-
fore, we assayed to assess in vitro differentiation of TFH cell 
with purified DCs. To avoid the possibility of indirect effects 
on T cells from DCBlimp-1ko mice, we used naive T cells from 
control mice. Naive T cells were cultured with DCs from   
either control or DCBlimp-1ko mice in the presence of differ-
entiation factors. Fig. 4 B shows that the generation of TFH 
cells was highly enhanced in cultures with Blimp-1ko DCs 
compared with control DCs. We confirmed the phenotype of 
TFH cells by demonstrating expression of Bcl-6, which is a 
principle transcription factor for TFH differentiation and is ex-
pressed exclusively in TFH. To test whether the increased TFH 
was a result of the increased level of IL-6 from DCs, DCs 
from IL-6+/ Blimp-1ko mice were assayed in culture. There 
was no increased differentiation of TFH in the presence of 
DCs from IL-6+/ Blimp-1ko mice, suggesting a direct in-
volvement of IL-6 from DCs in TFH differentiation (Fig. 4 B). 
Figure 4.  Increased TFH cells in DCBlimp-1ko mice in vivo and in vitro. (A) 6–10-wk-old control and DCBlimp-1ko mice were sacrificed and TFH  
(Lin (B220/CD11b/Gr-1), TCR-/CD4/CXCR5/PD-1+) were analyzed by flow cytometry. Total TFH cell number was calculated and graphed on the right. Each 
dot represents an individual mouse and horizontal bars indicate means of three independent experiments. (B) In vitro differentiation of TFH cells. Naive 
CD4+ T cells and splenic DCs were co-cultured and activated as described in Materials and methods. After 4 d, cells were harvested and the frequency of 
TFH cells was analyzed by flow cytometry. The top panel displays representative flow cytometry and the bottom is a summarized table (five independent 
experiments, n = 9). Total RNA was prepared from purified CD4+ T cells from each culture conditions, and the Bcl-6 level was measured by qPCR. The level 
of Bcl-6 of in vivo TFH cells (TFH cells sorted 12 d after NP immunization) was used as a positive control. Mean ± SD of three independent experiments is 
shown (n = 6).
Figure 5.  Decreased GC and TFH cells in IL-6+/ DCBlimp-1ko 
mice. Spleens were harvested from 6–8-wk-old mice, and  
GC B cells and TFH cells were enumerated by flow cytometry. 
Number of cells was calculated as percentage of positive cells × 
total splenocytes. Mean ± SD of three independent experiments 
is shown (n = 5).2198 Tolerogenic function of Blimp-1 in dendritic cells | Kim et al.
qPCR. Total RNA was extracted from purified DCs with RNeasy kit   
(Invitrogen) according to the manufacturer’s instructions and subjected to 
reverse transcription with iScript cDNA synthesis kit (Bio-Rad Laboratories). 
cDNA was analyzed by qPCR using LightCycler 480 probes master with 
various primers (Applied Biosystems). Relative induction of each gene of 
interest was calculated by Ct.
TFH cell in vitro differentiation. 105 purified DCs (CD11chi) from con-
trol and DCBlimp-1ko mice and 5 × 105 naive T cells (CD4+, CD62Lhi, and 
CD44lo) were co-cultured with anti-CD3 antibody precoated (145-2C11: 
5 µg/ml) 96-well plates. To induce TFH cell differentiation, TFH medium   
(10 µg/ml anti-IL-4 [11B11], 10 µg/ml anti–IFN- [XMG1.2], 10 µg/ml 
anti–TGF- [1D11], 30 ng/ml IL-6 [PeproTech], and 50 ng/ml IL-21 
[PeproTech]) was added. PBS alone and anti-CD3 alone without TFH me-
dium were used as a negative control. T cells were cultured for 4 d and TFH 
cells were analyzed by flow cytometry as described in Fig. S4 B. In some ex-
periments, anti–IL-6 neutralizing antibody (eBioscience) was added during 
the culture. CD4+ T cells were purified by anti-CD4 microbeads (Miltenyi 
Biotec) for Bcl-6 expression.
Additional  methods.  Information  on  serum  immunoglobulin  ELISA, 
Western blotting, ANA, antibodies, immunization with NP(16)-CGG, pro-
teinuria and IgG deposition in kidney, hybridoma generation, and Ig se-
quencing are available in the supplemental Materials and methods.
Statistics. Unpaired two-tailed Student t tests were used for statistical analy-
sis with Prism software (GraphPad Software). P < 0.05 was considered to be 
significantly different.
Online  supplemental  material. Fig. S1 shows Blimp-1 expression in 
hematopoietic lineages and additional phenotypes of DCBlimp-1ko mice. 
Fig.  S2  shows  gender-dependent  serology  and  secretion  of  IL-6  from   
B cells. Fig. S3 shows enhanced antibody and GC response in DCBlimp-1ko 
mice. Fig. S4 shows analysis of CD4+ T cells in the spleen of control and 
DCBlimp-1ko mice. Fig. S5 shows blocking of TFH by anti–IL-6 antibodies 
in vitro. Additional information is provided in the supplemental Materials 
and methods. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20110658/DC1.
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In summary, we propose a new mechanism for the devel-
opment  of  a  lupus-like  phenotype  mediated  by  Blimp-1, 
which is required to maintain tolerogenic function in DCs in 
a gender-dependent manner. The loss of function of Blimp-1 
in female DCs results in increased secretion of the critical 
proinflammatory cytokine IL-6, and in increased differentia-
tion of TFH cells and increased GC responses. It is of consid-
erable interest that a polymorphism of the Blimp-1 gene has 
now been implicated in both rheumatoid arthritis and SLE 
and that the phenotype of the DCBlimp-1ko mouse is analo-
gous to human SLE with a female bias, enhanced TFH cells, 
and increased IL-6 levels (Swaak et al., 1989).
MATERIALS AND METHODS
Mice. Blimp-1flox mice were provided by K. Calame (Columbia University, 
NY, NY) and backcrossed with C57BL/6 for eight generations. CD11c-
CRE mice were generated in the Reizis laboratory. DCBlimp-1ko mice and 
control mice were bred in the animal facility of The Feinstein Institution for 
Medical Research (FIMR) in specific pathogen-free conditions. IL-6ko mice 
(The Jackson Laboratory) were bred with DCBlimp-1ko mice in the animal 
facility of FIMR.
Purification of splenic DCs and in vitro generation of BM-DCs. 
CD11c+ splenic DCs were enriched with an EasySep kit (STEMCELL tech-
nologies) according to the manufacturer’s protocol. Then, CD11chi Siglec-H 
DCs were further purified by cell sorter (FACSAria; BD). Cell purity was 
routinely >95%.
To generate BM-DCs, BM cells were harvested from the femur with 
PBS. T cells and B cells were depleted by incubation with antibodies from 
hybridoma cell lines (American Type Culture Collection; TIB-120, TIB-
211, TIB 207, and TIB-146) with rabbit complement (Pel-Freeze Biologi-
cals). The remaining cells were cultured in RPMI 1640 with 10% FCS and 
200 ng/ml Flt3L (PeproTech) for 8 d. The nonadherent cells were collected. 
To measure cytokines in the supernatants, 106 DCs/ml were cultured over-
night in medium with or without 1 µg/ml LPS (Sigma-Aldrich).
ELISAs. Anti-dsDNA and anti-ENA5 (Sm, RNP, SS-A, SS-B, and Scl-70) 
antibodies were measured by a QUANTA Lite ELISA kit (INOVA Diagnos-
tics). Assays were performed as described in the protocol provided by manu-
facturer. In brief, serum samples were diluted in sample diluent at 1:101 and 
incubated in antigen-precoated plates for 30 min at room temperature (rt). 
Horse radish peroxidase (HRP)–conjugated isotype-specific anti-mouse IgG 
(1:2,000 SouthernBiotech) was added for 30 min at rt. Plates were washed   
after incubation, and TMB substrate was added for development. Absorbance 
(OD) was read for each well at 450 nm. L-6 ELISAs were performed with 
specific cytokine kits according to the manufacturer’s protocol (BD).
Histology of spleen and kidney. Spleens from 6–10-wk-old DCBlimp-1ko 
and control mice were fixed with 4% PFA and transferred to a 30%   
sucrose solution. The fixed spleens were snap frozen in Tissue-Tek O.C.T. 
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